DPhil in Oncology at University of Oxford

Programme overview

A research degree aimed at training leaders in translational oncology research, applying state-of-the-art techniques to the fundamental biology of cancer and the optimisation of treatments, with a focus on therapies involving drug discovery and combination therapies with radiotherapy.

Department: Department of Oncology | Duration: 3-4 years | Intake: 4 October 2027 | Study mode: full-time | Location: Oxford, England, United Kingdom

What you will study

The degree is based on a specific research project conducted in a single research group or laboratory, drawing on physics, biology, chemistry and mathematical modelling to study DNA biology, epigenetics, tumour cell and environmental biology, and immunological responses in cancer.

Official programme page

Application information

Entry requirements

A first-class or strong upper second-class UK honours degree (or equivalent) in a biological, medical, chemical, mathematical or physical science subject, as appropriate for the projects offered. Entrance is highly competitive and most successful applicants have a first-class degree or equivalent. A master's degree is not required but is an advantage. Applications are accepted from both basic scientists and clinicians. US bachelor's degree applicants normally need a GPA of at least 3.5 out of 4.0 (most successful applicants 3.7 or higher). English language (international applicants, standard level): IELTS Academic 7.0 overall with at least 6.5 in each component; TOEFL iBT 100 overall with minimum Listening 22, Reading 24, Speaking 25, Writing 24. Application deadline for 2027-28 entry: 12:00 UK time on 1 December 2026.

Domestic applicants: GBP 10,940 a year (2027/28) Source

International applicants: GBP 36,260 a year (2027/28) Source

Intake: 4 October 2027

Duration: 3-4 years full-time

Explore more study programmes

Health Sciences